Comprehensive Care for Brain and Spinal Tumors
| Patient Stories |
Meet Ben and read about his remarkable fight against a bithalamic brain tumor.
|
The Brain and Spinal Tumor Program at Cincinnati Children's Hospital Medical Center provides leading-edge, comprehensive care for children and young adults. Through innovative research and clinical care, we are improving treatment and long-term outcomes for patients with brain and spinal tumors.
The program serves approximately 800 patients from a broad geographic area. Some are newly diagnosed, and others come seeking novel therapies for recurrent tumors. Our physicians, researchers and other members of the medical team offer the full spectrum of the most technologically advanced care available. For example, the BrainSUITE™ at Cincinnati Children’s creates precise three-dimensional maps of the brain and safely guides our neurosurgeons in the removal of complex tumors. Cincinnati Children’s was the first pediatric hospital in the world to offer this technology.
Other examples of our advanced technology can be found in the pediatric radiotherapy program, a joint program with the Department of Radiation Therapy at the University of Cincinnati Barrett Cancer Center. It offers advanced, targeted treatments including shaped beam stereotactic radiation therapy, helical image-guided radiation therapy (IGRT), and intensity-modulated radiation therapy (IMRT).
Innovative research
Cincinnati Children's is a major referral center for the national Children’s Oncology Group, the National Cancer Institute's new Pediatric Phase I Consortium and the new Department of Defense Neurofibromatosis Clinical Consortium.
Cincinnati Children’s is also a member of the Collaborative Ependymoma Research Network (CERN) and is leading some studies through the Pediatric Brain Tumor Consortium. As such, our patients have access to the latest anti-cancer drug development clinical research studies, some of them pioneered right here at Cincinnati Children’s. Many of our physicians serve in leadership roles for these research organizations, further strengthening our link to the latest advances in clinical research and care.
The medical director of the Brain and Spinal Tumor Program is Maryam Fouladi, MD, MSc, FRCP, a national leader in brain and spinal tumor research and treatment. Dr. Fouladi has developed and led several national clinical research studies of leading-edge new therapies for these diseases.
